NASDAQ:ILMN
Illumina Stock News
$124.68
+1.63 (+1.32%)
At Close: May 01, 2024
Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?
05:45am, Tuesday, 20'th Jun 2023
Illumina's CEO resigned after its recent battles with regulators and shareholders. Its core segments aren't growing like they used to.
3 Gene Testing Stocks to Buy Before They Take Off
07:00am, Saturday, 17'th Jun 2023
Genes are the foundation of human life. They are the code that gives every instruction to our bodies about how to move, digest and think.
Illumina CEO Steps Down; Grail Soap Opera Continues
03:56pm, Friday, 16'th Jun 2023
And we interview Anjay Nagpal, host of the podcast "Brokers, Bagmen, and Moles."
Here's Why You Should Retain Illumina (ILMN) Stock for Now
12:28pm, Wednesday, 14'th Jun 2023
Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space.
Illumina acquisition of Grail wins support from GOP lawmakers, state AGs as FTC tries to block
05:42pm, Tuesday, 13'th Jun 2023
The groups argued in the briefs that the FTC overstepped its authority in trying to unwind Illumina's $7.1 billion acquisition of Grail.
Illumina CEO deSouza resigns after proxy battle with Carl Icahn
04:07pm, Monday, 12'th Jun 2023
Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb Illumina CEO Francis deSouza has stepped down after a lengthy proxy battle with activist investor Carl Icahn. Yahoo Finance health care reporter Anj
After Illumina CEO's Fall, Other Executives May Take Hard Look Before Deal Making
02:52pm, Monday, 12'th Jun 2023
Francis deSouza resigned from gene-sequencing maker after regulators challenged $7.1 billion deal, triggering proxy battle with Carl Icahn.
Is CEO Resignation a Sign That Carl Icahn Can Save Illumina (ILMN) Stock?
12:21pm, Monday, 12'th Jun 2023
Carl Icahn may be about to work his magic on another company. This week, reports surfaced that Illumina (NASDAQ: ILMN ) is gearing up for a change in leadership.
Illumina CEO resigns after proxy battle with Icahn
08:31am, Monday, 12'th Jun 2023
Illumina Inc (NASDAQ:ILMN), which has faced a bruising battle with activist investor Carl Icahn, said CEO Francis deSouza resigned as CEO with immediate effect on Sunday. The gene sequencing company n
5 Things to Know Before Markets Open
07:35am, Monday, 12'th Jun 2023
UBS completes its takeover of Credit Suisse and Biogen wins key FDA support for its Alzheimer's disease treatment. Here's what investors need to know today.
Illumina CEO resigns amid pressure from activist investor Carl Icahn
04:07pm, Sunday, 11'th Jun 2023
NEW YORK — Gene sequencing test maker Illumina Inc. said Sunday that its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately.
Francis deSouza just resigned as the CEO of Illumina Inc
02:14pm, Sunday, 11'th Jun 2023
Illumina Inc (NASDAQ: ILMN), on Sunday, said its board has accepted resignation from CEO Francis deSouza who's been leading the gene sequencing company since 2016. Charles Dadswell named interim CEO T
Illumina announces CEO transition plan as Francis deSouza resigns
10:07am, Sunday, 11'th Jun 2023
Illumina announced its board of directors has accepted the resignation of CEO Francis deSouza Sunday.
Illumina CEO Francis deSouza Resigns
10:03am, Sunday, 11'th Jun 2023
Head of gene-sequencing test maker steps aside after regulators challenged deal for a cancer test-developer.
Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger
10:57am, Friday, 09'th Jun 2023
Illumina's (ILMN) total sequencing activity on connected high- and mid-throughput instruments are growing strongly.
